Researchers created an AI-driven liquid biopsy that scans patterns in fragments of DNA circulating in the blood. The system detected early liver fibrosis and cirrhosis—conditions that often go ...
A high-profile Central Florida couple continues fighting to change state and federal law to expand newborn requirements.
When parts of the small intestine are diseased or die, the treatment can involve surgically removing the affected tissue. Although lifesaving, the procedure—referred to as a radical small bowel ...
Altimmune (ALT) stock dips as higher-than-expected R&D costs lead to a Q4 2025 earnings miss for the company. Read more here.
Advanced Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV) in 2025 with Topline Results from North American C-BEYOND Trial Expected Mid-2026 and Topline Results from C-FORWARD Trial Outs ...
Toronto General Hospital climbed up to the No. 2 spot—and knocked down Cleveland Clinic—on World's Best Hospitals.
Cash and Investments -- $301.8 million as of December 31, 2025, sufficient to fully fund current Phase III HCV and new HEV programs through 2027. Phase III HCV Trials -- C BEYOND enrollment completed ...
Advanced Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV) in 2025 with Topline Results from North American C-BEYOND Trial Expected Mid-2026 and Topline Results from C-FORWARD Trial Outs ...
Approval based on unprecedented Phase 3 data demonstrating statistically significant improvements in progression-free survival and overall survival versus standard of care regimens83.3% of ...
The Times of Israel on MSN
Israeli researchers find cannabis compounds could lead to 1st drug for fatty liver disease
As 1 out of every 3 adults worldwide suffers from the condition, Hebrew University scientists use non-psychoactive substances ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results